Trial intelligence / Profile preview

Cytoimplant vs Gemcitabine in Advanced Pancreatic Cancer

NCT00003780Phase 2Unknown

Sponsor
Meyer Pharmaceuticals Ltd.
Start
Dec 1998
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of cytoimplant in pancreatic cancer (PC), sponsored by Meyer Pharmaceuticals Ltd.. Status: unknown.

02

Drugs

cytoimplant
03

Conditions

pancreatic cancer (PC)

Beyond the preview

Go deeper on NCT00003780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call